This Little Known Chinese Herb Kills 12,000 Cancer Cells For Every Healthy Cell
Today,
odds are that you have had/have cancer, or know somebody who does. In
Canada, approximately one million Canadians that were alive at the
beginning of 2009 have had a cancer diagnosis in the previous 10 years.
Two out of every five Canadians will develop cancer within their life
time, and one in every four will die.(3) In the United States, one out of every two men, and one out of ever three women will become infected with cancer.
These rates have continued to skyrocket
since we started recording them and more people are starting to ask
questions and observe the environment we choose to surround ourselves
with on a daily basis.
Despite these statistics, new research
is emerging everyday that puts into question the only two approved
treatments for cancer, which are radiation and chemotherapy. It seems we
are approaching a time where the medical community will be forced to
open up to new options when it comes to cancer treatment. After all,
scientists have discovered that chemotherapy fuels cancer growth and
kills the patient more quickly, yet nothing has been changed, both are
extremely toxic to the human body.
A little known Chinese herb might be
eligible for the growing list of cancer killers via alternative methods
of treatment. According to studies published in Life Sciences, Cancer Letters and Anticancer Drugs,
artemesinin, a derivative of the wormwood plant commonly used in
Chinese medicine, can kill off cancer cells, and do it at a rate of
12,000 cancer cells for every healthy cell. (0)
Henry Lai and his team of researchers
from the University of Washington synthesized the compound, which uses a
cancer cells appetite for iron to make them the target. The great thing
about artemisinin is that alone it can selectively kill cancer cells
while leaving normal cells unharmed.
“By itself, artemisinin is about
100 times more selective in killing cancer cells as opposed to normal
cells. Artemisinin is 34,000 times more potent in killing the cancer
cells as opposed to their normal cousins. So the tagging process appears
to have greatly increased the potency of artemisinin’s cancer-killing
properties.” - Henry Lai
Despite the compound being licensed to Holley Pharmaceuticals, it has yet to be used for cancer treatment in humans.
“We call it a Trojan
horse because the cancer cell recognizes transferrin as a natural,
harmless protein. So the cell picks up the compound without knowing that
a bomb (artemisinin) is hidden inside.” - Henry Lai
The wormwood extract was used many
centuries ago in China for healing purposes. The treatment became lost
over time and has now been rediscovered thanks to an ancient manuscript
containing medical remedies. It kills 12,000 cancer cells for every
healthy cell, which means it could be turned into a drug with minimal
side effects.
“The
compound is currently being licensed by the University of Washington to
Artemisia Biomedical Inc., a company that Lai, Sasaki and Narendra
Singh, UW associate professor of bioengineering, founded in Newcastle,
Washington for development and commercialization. Human trials are at
least several years away. Artemisinin is readily available, Sasaki said,
and he hopes their compound can eventually be cheaply manufactured to
help cancer patients in developing countries.” (0)
The abstracts read:
“Artemisinin reacts with iron to
form free radicals that kill cells. Since cancer cells uptake
relatively larger amounts of iron than normal cells, they are more
susceptible to the toxic effect of artemisinin. In previous research, we
have shown that artemisinin is more drawn to cancer cells than to
normal cells. In the present research, we covalently attached
artemisinin to the iron-carying plasma glycoprotein
transferrin.Transferrin is transported into the cells via
receptor-mediated endocytosis and cancer cells express significantly
more transferrin receptors on their cell surface and endocytose more
transferrin than normal cells. Thus, we hypothesize that by tagging
artemisinin to transferrin, both iron and artemisinin would be
transported into cancer cells in one package. Once inside a cell, iron
is released and can readily react with artemisinin close by tagged to
the transferrin. This would enhance the toxicity and selectivity of
artemisinin towards cancer cells. We found that holotransferrin-tagged
artemisinin, when compared with artemisinin, was very potent and
selective in killing cancer cells. Thus, this ‘tagged-compound’ could
potentially be developed into an effective chemotherapeutic agent for
cancer treatment.” (1)
Another abstract reads:
“Our results demonstrate that
the artemisinin disruption of E2F1 transcription factor expression
mediates the cell cycle arrest of human breast cancer cells and
represents a critical transcriptional pathway by which artemisinin
controls human reproductive cancer cell growth.” (2)
Artemisinin is currently FDA approved
for the treatment of malaria, it’s very safe and easy to use. It’s
inexpensive and works on all cancers but has yet to find it’s way into
the mainstream. It’s really time to move beyond just radiation, surgery
and chemotherapy for the treatment of cancer.
Sources:
No comments:
Post a Comment